MICHAEL CORYEA: Open Payments
NPI 1366985046 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$121 in 6 payments from 4 companies in 2025. Trend: 2023 $81 · 2024 $213 · 2025 $121
Food & beverage: $121
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $71 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: CAPLYTA, REXULTI, COBENFY, Auvelity.
Industry payments across IN — which companies pay providers there.
